Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China

被引:2
|
作者
Yao, Yao [1 ]
Zhou, Hanchu [1 ]
Cao, Zhidong [2 ]
Zeng, Daniel Dajun [2 ]
Zhang, Qingpeng [3 ,4 ,5 ]
机构
[1] City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China
[2] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China
[3] Univ Hong Kong, Musketeers Fdn Inst Data Sci, Hong Kong, Peoples R China
[4] Univ Hong Kong, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[5] Univ Hong Kong, Musketeers Fdn Inst Data Sci, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
关键词
Covid-19; reinforcement learning; artificial intelligence; machine learning; mathematical modelling; infectious diseases;
D O I
10.1093/jamia/ocad116
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background Long-lasting nonpharmaceutical interventions (NPIs) suppressed the infection of COVID-19 but came at a substantial economic cost and the elevated risk of the outbreak of respiratory infectious diseases (RIDs) following the pandemic. Policymakers need data-driven evidence to guide the relaxation with adaptive NPIs that consider the risk of both COVID-19 and other RIDs outbreaks, as well as the available healthcare resources. Methods Combining the COVID-19 data of the sixth wave in Hong Kong between May 31, 2022 and August 28, 2022, 6-year epidemic data of other RIDs (2014-2019), and the healthcare resources data, we constructed compartment models to predict the epidemic curves of RIDs after the COVID-19-targeted NPIs. A deep reinforcement learning (DRL) model was developed to learn the optimal adaptive NPIs strategies to mitigate the outbreak of RIDs after COVID-19-targeted NPIs are lifted with minimal health and economic cost. The performance was validated by simulations of 1000 days starting August 29, 2022. We also extended the model to Beijing context. Findings Without any NPIs, Hong Kong experienced a major COVID-19 resurgence far exceeding the hospital bed capacity. Simulation results showed that the proposed DRL-based adaptive NPIs successfully suppressed the outbreak of COVID-19 and other RIDs to lower than capacity. DRL carefully controlled the epidemic curve to be close to the full capacity so that herd immunity can be reached in a relatively short period with minimal cost. DRL derived more stringent adaptive NPIs in Beijing. Interpretation DRL is a feasible method to identify the optimal adaptive NPIs that lead to minimal health and economic cost by facilitating gradual herd immunity of COVID-19 and mitigating the other RIDs outbreaks without overwhelming the hospitals. The insights can be extended to other countries/regions.
引用
收藏
页码:1543 / 1551
页数:9
相关论文
共 24 条
  • [21] Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study
    Clipman, Steven J.
    Wesolowski, Amy P.
    Gibson, Dustin G.
    Agarwal, Smisha
    Lambrou, Anastasia S.
    Kirk, Gregory D.
    Labrique, Alain B.
    Mehta, Shruti H.
    Solomon, Sunil S.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1822 - E1829
  • [22] Immediate and long-term changes in the epidemiology, infection spectrum, and clinical characteristics of viral and bacterial respiratory infections in Western China after the COVID-19 outbreak: a modeling study
    Shi, Tianshan
    Zhao, Xin
    Zhang, Xiaoshu
    Meng, Lei
    Li, Donghua
    Liu, Xinfeng
    Zheng, Hongmiao
    Yu, Deshan
    Wang, Tingrong
    Li, Rui
    Li, Juansheng
    Shen, Xiping
    Ren, Xiaowei
    ARCHIVES OF VIROLOGY, 2023, 168 (04)
  • [23] Immediate and long-term changes in the epidemiology, infection spectrum, and clinical characteristics of viral and bacterial respiratory infections in Western China after the COVID-19 outbreak: a modeling study
    Tianshan Shi
    Xin Zhao
    Xiaoshu Zhang
    Lei Meng
    Donghua Li
    Xinfeng Liu
    Hongmiao Zheng
    Deshan Yu
    Tingrong Wang
    Rui Li
    Juansheng Li
    Xiping Shen
    Xiaowei Ren
    Archives of Virology, 2023, 168
  • [24] Epidemiological study of respiratory virus infections among hospitalized children aged 14 years and younger during COVID-19 pandemic in Wuhan, China, 2018-2022
    Hao, Yingchan
    Cheng, Li
    Lu, Dan
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2023, 15 (04) : 149 - 155